Although some progress has been made in our understanding of pancreatic carcinogenesis, the cause of this highly malignant disease still remains unknown. It generally grows without presenting symptoms until late in its history and thus poses many problems for the diagnosing physician. A mere 5-22% of tumours are detected early enough to allow radical resection (Trede et al, 1990; Eskelinen et al, 1991; Warshaw and Fernandez-del Castillo, 1992; Janes et al, 1996) , the only hope for cure. Although in recent selective studies, 5-year survival rates of up to 17-27% have been reported for curative resection of pancreatic cancer (Trede et al, 1990 (Trede et al, , 1998 Warshaw and Fernandez-del Castillo, 1992; Yeo et al, 1995) , even those patients surviving pancreatic cancer for 5 years often die of local or metastatic late recurrence (Trede et al, 1998 ). It appears that the results of surgical treatment alone have reached a plateau in pancreatic cancer.
a preliminary study, we have reported that a tumour cell line (DSL-6A/C1), originally derived from an azaserine-induced primary tumour (Pettengill et al, 1993) , produced a solid and uniformly growing tumour when it was transplanted subcutaneously (s.c.) (Mäkinen et al, 1998) . However, there are no studies available on the growth pattern and microvasculature of rat intrapancreatic tumours induced with cultured carcinoma cells. In this study we describe the tumour take, growth and microvasculature, and subsequently evaluate the feasibility of this animal model for use in pancreatic cancer studies.
MATERIALS AND METHODS

Animals
Male Lewis rats (n = 120) were obtained from Charles River Laboratories (Sulzfeld, Germany). For transplantation, 5-week-old rats (± 1 week) with initial weights of about 100 g were used. Studies and growth characteristics were based on five different transplantation series. The animals were kept under standard laboratory conditions, fed a chow diet, observed daily and autopsied if showing lethargy, ulcers, swelling or weight loss. All animal procedures were approved by the Animal Care and Use Committee of the University of Kuopio.
Tumour cell line and transplantation
Tumour cell line DSL-6A/C1 (ATCC CRL-2132) was obtained from an acinar cell carcinoma (DSL-6) of rat pancreas (Pettengill et al, 1993) . Cell culture and characteristics of s.c. transplanted tumours have been reported previously (Pettengill et al, 1993; Mäkinen et al, 1998) . In brief, for pancreatic tumour induction, 20 µl containing 2 × 10 6 carcinoma cells were injected through the pancreatic capsule into the pancreatic tissue at the splenic lobe ( Figure 1 ) using Hamilton syringe (Hamilton Bonaduz AG, Switzerland) with 26-gauge needle and a stereotactic apparatus (Kopf, Germany). To prevent carcinoma cell spread after the injection, Tisseel fibrin glue (Immuno AG, Austria) was applied over the pancreas around the needle and after a 1-min delay the needle was slowly withdrawn.
Tissue samples
At autopsy, 2-28 weeks after tumour induction, all tumours were removed, and their dimensions measured. The samples were then processed for light microscopy studies. The tumour volume was calculated in cubic centimeters. Abdomen and thoracic cavity were examined systematically throughout and all abnormal tissues were sampled and processed for microscopic examination.
Microangiography
The method used has been described earlier (Kormano, 1967) . Microangiography studies were carried out in untreated (n = 2) as well as in tumour-bearing animals (n = 7). Microangiography was performed by infusing 10% barium sulphate solution (Micropaque R , Nicholas, France) into the abdominal aorta under 80-120 mmHg pressure until the pancreatic microvasculature was filled with contrast material. The whole pancreas was then removed and fixed in 4% buffered formaldehyde solution and embedded in paraffin. Five hundred-micrometer sections were cut for microangiography and adjacent 5 µm sections were cut and stained with haematoxylin and eosin (H&E) for histological studies. The microangiography slices were X-rayed with high resolution plates (Kodak R ), using a Siemens X-ray tube equipped with a tungsten anode and a beryllium window. The focus-to-film distance was 53 cm, and exposure values were 18 min, 40 kV and 20 mA. H&E samples were used for orientation and to confirm the borders of the tissue structures.
Statistical analysis
In statistical analysis, the SPSS/PC+ program package (SPSS Inc, Chicago, II, USA) was used.
RESULTS
Recovery after successful tumour cell inoculation was uneventful. The tumour take was 64% (77/120). At laparotomy the earliest palpable nodules were found 2 weeks after inoculation, but in some animals tumours became palpable only after 15 weeks. If there had been any technical problems in inoculation (i.e. carcinoma cell spreading) tumour tissue was found also around the peritoneum, mainly in the wound scars already after 2 weeks. The increase in tumour volume is shown in Figure 2 . After 20 weeks the tumours usually had attained 1 cm 3 volume and in half of the experimental animals the tumours were still local. The others showed invasive growth around the peritoneum, gut mesentery, spleen, liver hilus, liver, kidneys and retroperitoneum. Ulcerative growth through the abdominal wall was found in the largest tumours. No distant metastases were found outside the abdomen. The consistency of tumours were hard. The cut surface was homogenous and pale, however, cystic changes were found in the largest (> 2.0 cm 3 ) tumours as well as the necrotic areas. Desmoplasia was a common finding. Tumour infiltrating lymphocytes and plasma cells as well as the granulocytes and giant cells of foreign type were found, although the inflammatory reaction was usually mild. All tumours were ductal adenocarcinomas showing usually moderate differentiation grade (Figure 3) . No signs of perineural invasion were found. The microvasculature, as well as arterioles and arteries, of pancreases were well filled with contrast medium. No ruptured vessels were found. Microangiography of normal rat pancreata showed that the vessels sprout like branches into a dense capillary network around pancreatic acini. The capillary structure was regular in shape and size. Pancreatic tumours exhibited deficits in their microcirculation. Tumour vessels were irregularly organized, slender, thin and straight 'finger-like' structures. There were avascular areas in the centre of the tumours. The peritumoural area showed dense neovascularization and vessel invasion (Figure 4 ).
DISCUSSION
We have previously found that a tumour cell line (DSL-6A/C1) derived from azaserine-induced rat pancreatic tumour (Pettengill et al, 1993 ) produced a solid and uniformly growing tumour when it was transplanted s.c. into the Lewis rat (Mäkinen et al, 1998) . However, our long-term strategy was to establish an intrapancreatic tumour model with a solid tumour nodule in the pancreas for pancreatic cancer studies, to be subjected to detailed examination in gene therapy studies.
In this experimental study we have demonstrated a reasonable tumour take and reproducible growth pattern after intrapancreatic tumour cell inoculation. In our series, 77 of 120 animals had pancreatic tumours when autopsied. A number of animals did not have palpable tumours until 15 weeks after cell inoculation. Since a few animals were autopsied before 15 weeks, those animals which did not have tumours at that time, would after all become tumour-bearing if they would have lived longer. Consequently, we believe that the actual tumour take was somewhat higher than 64%.
We conducted five different transplantation series and tumour take varied between these series although the cell culture, harvesting, animal age and inoculation techniques were similar. One explanation may be that tumourigenicity of the cell line varies. It is also possible that immunocompetent animals can destroy tumour cells to varying degrees. Although the inflammatory reaction within the tumours and in the peritumoural area was usually mild, some variation did exist. Interestingly, some animals that did not have tumours had inflammatory reaction with giant cells of foreign type, and some had also few atypical ductal cells as well as desmoplasia. In addition, some samples showed intense inflammation, as seen in the number of plasma cells and lymphocytes. This may be a reflection of immune rejection and tumour cell killing through graft-versus-host response. Consequently, if we had used immunodeficient animals the results might have been more favourable in regard to induction of tumours. However, the Intrapancreatic tumour induction with small fragments of rapidly growing azaserine-induced primary tumour was originally presented by Longnecker (1981) . In this model pancreatic tumours grew rapidly, reaching 2-3 cm dimension in 3 weeks. This model has been adapted in intrapancreatically as well as in s.c.-induced tumours Karsently et al, 1993; Evrard et al, 1994) . Although tumours induced with cultured cells grew more slowly, experimental tumours induced with a homogenous cell population may offer advantages with respect to similar biological behaviour. Our results concerning the phenotype and growth characteristics seem to confirm this hypothesis. Furthermore, a rodent tumour model with slowly progressing malignant tumour may provide better predictability when compared with models of very rapidly dividing and spreading rodent carcinoma cells.
In rats, azaserine treatment produces pancreatic tumours that arise from altered acinar cells (Longnecker, 1987) . However, when these tumour cells were cultured and regrafted s.c. in Lewis rats, they produced duct-like carcinoma (Pettengill et al, 1993) . As presented previously (Mäkinen et al, 1998) and in this study, intrapancreatic tumours induced with cultured cells also exhibited a ductal phenotype. The reason for this phenotypic plasticity has been discussed previously (Hall and Lemoine, 1993; Pettengill et al, 1993) . Although DSL-6A/C1 cells produce ductal pancreatic carcinoma, there are some similarities with this tumour model and human acinar cell carcinoma of the pancreas as reported previously (Klimstra et al, 1992) . The metastatic disease in their material was largely limited to the upper part of the abdomen. They also found recurrent tumour in the abdominal or chest wall and considered this as a consequence of carcinoma implantation in the surgical resection tracts. In our experimental model, the tumour spread was also limited to intra-abdominal organs and tumour dissemination to the abdominal wall around the scars was a common finding.
Experimental tumours showed deficits in their microvasculature with the shape of vessels being straight but their structure irregular. This is due, at least in part, to the necrosis and desmoplasia found in tumours. Previously, the microangiography technique has been used to analyse microcirculatory changes in experimental pancreatitis and hypovolemic shock (Nuutinen et al, 1986 (Nuutinen et al, , 1988 . These studies showed that poor filling of capillaries during haemorrhagic or necrotizing pancreatitis may be due to disruption of capillaries, vascular thrombosis or shunting of blood away from the capillary circulation. In addition, pancreatic ducts in the necrotic areas of severe acutic pancreatitis, as well as the ductal walls in chronic pancreatitis, showed a decrease in their vascularity (Pitkäranta et al, 1991) . The dense vessel network in the peritumoural area was a particularly interesting finding of the present study. This may be a consequence of angiogenic switch, through changes in the balance between angiogenic activators and inhibitors (Hanahan and Folkman, 1996) . Consequently, the tumour cells may either induce the production or even synthesize themselves mediators that stimulate angiogenesis, an essential factor for expansion of the tumour mass. This could be elucidated by analysing known angiogenic inducers, such as vascular endothelial growth factor and fibroblast growth factors before and during tumourigenesis. However, this is only one of many problems remaining to be answered.
We observed that a tumour cell line (DSL-6A/C1), derived from an azaserine-induced rat pancreatic tumour (DSL-6), produced a solid and uniformly growing tumour when transplanted intrapancreatically into the Lewis rat, providing a feasible model for pancreatic cancer studies.
